Sign in Subscribe
Brain cancer

Quality-Adjusted Life Years in Brain Tumor Patients: New Insights

Strategic Insights

— 2 min read

Researchers at Technical University Munich (TU Munich) have published a comprehensive study on the quality-adjusted life years (QALYs) of brain tumor patients. The study, which was conducted between 2016 and 2019, aimed to assess the health preferences of patients with eloquent tumors, which are located in brain regions critical for language, motor, or sensory function. The research, which has been peer-reviewed, found that while postoperative health status initially declines, resilience and adaptation occur over time, emphasizing the need for tailored postoperative care.

Key Takeaways:

  • The study involved 78 patients with eloquent brain tumors who underwent standardized assessments at four time points: preoperative, postoperative, and at 3- and 6-month follow-ups.
  • The patients used various instruments, including Time Trade-Off (TTO), Standard Gamble, EuroQol 5 Dimensions (EQ-5D), and the Beck Depression Inventory (BDI), to indicate how many years from a 10-year life span they would trade to live in perfect health.
  • The resulting values, ranging from 0 to 1, were calculated and analyzed using Mann-Whitney U-tests. Preoperatively, 78 patients reported high quality of life, with a median TTO value of 0.9.
  • The EQ-5D index declined significantly after surgery (p=0.022).
  • While postoperative health status initially declines, resilience and adaptation occur over time, emphasizing the need for tailored postoperative care.
  • This research has been peer-reviewed and published in the International Journal of Cancer (2025).
  • The study highlights the importance of considering the quality of life in brain tumor patients, in addition to survival analysis, when evaluating treatment outcomes.
  • The research found that patients with eloquent tumors were willing to trade off years from their life expectancy to achieve perfect health, with TTO values ranging from 0 to 1.
  • The study's findings suggest that the resilience and adaptation of patients with eloquent tumors over time may be associated with improved health outcomes.

Statistics:

  • 78 patients with eloquent brain tumors participated in the study.
  • The patients underwent standardized assessments at four time points: preoperative, postoperative, and at 3- and 6-month follow-ups.
  • The TTO median value was 0.9 preoperatively.
  • The EQ-5D index declined significantly after surgery (p=0.022).
  • The patients reported a range of TTO values from 0 to 1.

Sources:

  • NewsRx. New Data from Technical University Munich (TU Munich) Illuminate Findings in Brain Cancer [Prospective Inter-individual Analysis of Quality-adjusted Life Years (Qalys) In Brain Tumor Patients: a Comprehensive Assessment of Health Preferences]. Health & Medicine Week. October 24, 2025; p 2484.
  • International Journal of Cancer. (2025). Prospective Inter-individual Analysis of Quality-adjusted Life Years (Qalys) In Brain Tumor Patients: a Comprehensive Assessment of Health Preferences. (Vol. 137, Issue 5).
  • Technical University Munich (TU Munich). School of Medicine and Health. (n.d.). Our Research. Retrieved from
  • Project DEAL. (n.d.). Project DEAL. Retrieved from

Read more